PLUS Diagnostics, Inc.

PLUS Diagnostics, Inc.

PLUS Diagnostics, Inc.

Overview
Date Founded

1990

Headquarters

825 Rahway Avenue,Union, NJ 07083

Type of Company

Private

Industries

Medical Support Services
Hospitals & Patient Services

Company Description

PLUS Diagnostics, Inc. provides comprehensive pathology services. The firm specializes in genitourinary and gastrointestinal pathology, breast pathology, dermatopathology, hematopathology, oral and maxillofacial pathology. The company was founded in 1990 and is headquartered in Union, NJ.

Contact Data
Trying to get in touch with decision makers at PLUS Diagnostics, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Financial Officer

Executive Vice President

Chief Executive Officer

Chief Operating Officer

Controller

Medical Director

Medical Director

Director

Coordinator

Vice President, Human Resources

Board of Directors

Founder at Water Street Healthcare Partners LLC

Partner at Water Street Healthcare Partners LLC

Paths to PLUS Diagnostics, Inc.
Potential Connections via
Relationship Science
You
PLUS Diagnostics, Inc.
Recent Transactions
Details Hidden

Inform Diagnostics, Inc., Miraca Holdings, Inc. purchase PLUS Diagnostics, Inc. from Water Street Healthcare Partners LLC

Details Hidden

Water Street Healthcare Partners LLC purchases PLUS Diagnostics, Inc.

Non-Profit Donations & Grants
Investors
Details Hidden

Water Street Healthcare Partners focuses exclusively on investments in the healthcare sector. The firm invests in middle-market companies and lower-priority divisions of global companies in the following areas: diagnostic devices, medical products, pharmaceutical services, specialty distribution, specialty pharmaceuticals and specialty services. Water Street does not invest in biotechnology, traditional healthcare facilities such as hospitals or nursing homes or in early-stage companies without positive cash flow. They firm looks for companies with: (1) a leading market share (2) established brands and/or strong customer relationships (3) strong sales and distribution capabilities (4) platforms with the potential for expansion into new products, services and technologies and (5) management teams interested in retaining an ownership stake. Investments typically range from $50 million to $500 million.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by PLUS Diagnostics, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of PLUS Diagnostics, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and PLUS Diagnostics, Inc..
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://news.relsci.com/organization/plus-diagnostics-inc-689657
  • https://news.relsci.com/organization/plus-diagnostics-inc-689657